March 6, 2012 — TeraRecon announced the release of version 4.4.7 of its iNtuition enterprise advanced visualization image management solution, with enhanced support for interoperability and Quantitative Imaging, at the 23rd European Congress of Radiology (ECR) meeting in Vienna, Austria, in March 2012.

March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration (FDA), Health Canada and Conformité Européenne (CE) approved Total Artificial Heart, announced that 18-year-old Jordan Merecka was successfully bridged to a heart transplant at Texas Children’s Hospital in Houston, Texas, after 160 days of support with the SynCardia temporary Total Artificial Heart.

March 5, 2012 — Emerge Clinical Solutions announced its strategic relationship with MedAxiom, a comprehensive subscription-based service provider and information resource exclusively for cardiology practices.

March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now